Home/Pipeline/ALLOCYTE® Plus Advanced Viable Bone Matrix

ALLOCYTE® Plus Advanced Viable Bone Matrix

Bone Grafting

Approved/CommercialMarketed

Key Facts

Indication

Bone Grafting

Phase

Approved/Commercial

Status

Marketed

Company

Sanara MedTech

About Sanara MedTech

Sanara MedTech is a Texas-based medical technology company with a mission to improve clinical outcomes and reduce healthcare expenditures through transformative surgical and wound care products. The company has successfully commercialized a portfolio of regenerative medicine products for soft tissue repair and surgical site management, establishing a revenue-generating foundation. Its strategic focus is now on advancing its flagship OsStic™ bone bioadhesive technology, a high-potential platform with FDA Breakthrough Device Designation, while leveraging its commercial infrastructure for growth.

View full company profile

Therapeutic Areas

Surgical/Wound Management Orthopedic Trauma Bone Repair

Other Bone Grafting Drugs

Drug	Company	Phase	Status
OsteoAMP / AlloFuse	Bioventus	Commercial	Active
BioSphere® PUTTY	Synergy Biomedical	Approved	Active
DBLogix / CeLLogix	Omnia Medical	Commercial	Active
ACTIGEN™ Verified Inductive Bone Matrix	Sanara MedTech	Approved/Commercial	Marketed